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Abstract
Introduction: The NF-kB transcription factor family regulates several genes encoding pro-inflammatory and anti-
inflammatory proteins in adipose tissues and in atherosclerotic plaques. The deletion variant allele of the NFKB1 - 94ins/
delATTG promoter polymorphism leads to lower transcript levels of the p50 subunit, and the variant allele has been
associated with the risk of several inflammatory diseases as well as coronary heart disease where inflammation is important
in the pathogenesis. The objective of this study was to explore the potential interaction between the NFKB1-94ins/delATTG
promoter polymorphism and general, abdominal, and gluteofemoral obesity in relation to the risk of incident acute
coronary syndrome (ACS) in three large independent cohorts.
Methods and Results: The analyses were conducted in the Danish prospective study Diet, Cancer and Health and the two
US based cohorts; Nurses’ Health Study and Health Professionals Follow-up Study. We conducted sex stratified analyses that
included 1202 male and 708 female cases of incident ACS. We observed a positive association for general and abdominal
obesity with risk of incident ACS, independent of genotype in both genders. Gluteofemoral obesity was negatively
associated with ACS risk in women independent of genotype, whereas there was no clear association for men. We
calculated the relative excess risk due to interaction (RERI) and observed a statistically significant excess risk among men
jointly exposed to general or abdominal obesity and the variant allele of the NFKB1-94ATTG polymorphism, whereas there
was a tendency towards sub-additivity for gluteofemoral obesity. The excess risks in all analyses were, however, small and
could not clearly be demonstrated in women.
Conclusion: The variant allele of the NFKB1-94ins/delATTG promoter polymorphism did not substantially modify the
association between obesity and incident ACS.
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Introduction
Obesity is associated with a higher risk of acute coronary
syndrome (ACS)[1–4]. However, many obese do not experience
ACS, and other factors may affect the implications of obesity.
Adipose tissue is, in addition to being a storage organ for energy,
an active endocrine organ that secretes both pro- and anti-
inflammatory cytokines [5]. As obesity develops, the release of
adipose tissue derived cytokines increases [6], and the resulting
state of chronic low-grade inflammation may accelerate the
PLOS ONE | www.plosone.org 1 May 2013 | Volume 8 | Issue 5 | e63004atherosclerotic processes in the arterial wall, and thus lead to the
increased risk of ACS[6–8].
Many genes encoding pro-inflammatory and some genes
encoding anti-inflammatory proteins in both adipose tissues and
atherosclerotic plaques are regulated by the NF-kB transcription
factor family[6,9–11]. The NF-kB family consists of heterodimeric
or homodimeric combinations of five subunits (p50, p100,
RelA(p65), RelB and c-Rel), and different combinations have
different target genes. The p50/p50 homodimer represses
transcription of pro-inflammatory cytokines like TNFalpha and
IL-12 and promotes transcription of the anti-inflammatory IL-10
[10,11].
The NFKB1–94ins/delATTG promoter polymorphism is an
insertion/deletion of four bases in the promoter region of the
NFKB1 gene encoding the p50 subunit, and the variant allele
containing the deletion produces lower transcript levels of the p50
subunit [12]. The NFKB1 - 94ins/delATTG promoter polymor-
phism is the only functional polymorphism in NFKB1 [12] and the
polymorphism has been associated with both the inflammatory
marker CRP and diseases where inflammation is important in the
diseases pathogenesis including ACS[12–14]. The NFKB1 - 94ins/
delATTG promoter polymorphism is not a single nucleotide
polymorphism (SNP) and thus not detected directly by genome
wide association scans. However, the NFKB1 - 94ins/delATTG
promoter polymorphism is in high linkage disequilibrium with
rs230529 and rs4699030 (r
2=0.741 and 0.714, respectively) [15],
but as indicated by the r
2 of 0.7 the SNPs were not in complete
linkage disequilibrium with the NFKB1 - 94ins/delATTG
promoter polymorphism.
The objective of this study was to explore the potential biologic
interaction between the NFKB1–94ins/delATTG promoter poly-
morphism and obesity in relation to the risk of incident ACS.
Results
Baseline characteristics of the study participants are presented in
Table 1. Compared to the controls both male and female cases in
DCH appeared on average older, had a shorter education, fewer
were never smokers, and drank less alcohol. In NHS and HPFS,
age and smoking status were matching factors, and thus no
differences were observed, but as in DCH, cases drank less alcohol
than controls. In all studies, cases had a higher prevalence of
hypertension, diabetes mellitus and hypercholesterolemia at
baseline. Only few were current smokers in HPFS compared to
NHS and DCH, and there were higher prevalence’s of hyperten-
sion, hypercholesterolemia and diabetes mellitus in the two US
cohorts.
The primary anthropometric exposure variables are presented
in Table 2. Among the controls the minor allele (the deletion
variant) frequency was 37%–39%, and the NFKB1 genotype
distribution was in Hardy-Weinberg equilibrium in all three
studies (data not shown).
Both general obesity, measured as BMI, and abdominal obesity,
measured as WC, were positively associated with ACS indepen-
dent of genotype. Carrier status did not have a consistent effect on
ACS risk among the lean reference groups, but the risk of ACS
was highest among the jointly exposed to both the variant allele
and obesity (Table 3 and Table 4). Due to the negative association
between gluteofemoral obesity measured as HC and ACS, the HC
variable was inverted, and the group with the highest HC was the
reference group (Table 5). In the lean men, the variant allele was
associated with a higher risk of ACS in DCH and in the pooled
estimates, but there was no association among the lean females.
Gluteofemoral obesity was negatively associated with ACS risk
among women with no consistent effect of genotype, whereas we
observed no clear association in men.
We explored the possible interaction between obesity and
carrier status by calculating the relative excess risk due to
interaction (RERI) (Table S1). In men the combined effects of
the NFKB1 - 94ins/delATTG promoter polymorphism and
general or abdominal obesity showed a tendency towards positive
interaction. Likewise, we found a tendency towards negative
interaction, i.e. subadditivity, for the combined effect of the
NFKB1 - 94ins/delATTG promoter polymorphism and gluteofe-
moral obesity. However, the estimates for the excess risk were
small and could not clearly be demonstrated in women.
Discussion
In this large prospective study conducted in three independent
cohorts, we observed no substantial interaction between obesity
and the NFKB1 - 94ins/delATTG promoter polymorphism in
relation to the risk of incident ACS; however, joint exposure to
general or abdominal obesity and the variant allele was associated
with the highest risk of ACS.
Strengths and Limitations
We achieved a high level of endpoint ascertainment as cases
were validated by direct review of medical records. Likewise, data
on anthropometric exposure variables were collected by trained
study technicians in DCH, but in NHS and HPFS anthropometric
measures were self reported, which could lead to measurement
errors. However, all participants in NHS and HPFS were health
workers, and the self reported measures have been validated, albeit
there was a tendency towards underestimation of obesity measures
[16]. Due to the subtle nature of atherosclerosis, reverse causation
in relation to the anthropometric variables was a possibility, but we
have previously in the total DCH cohort found similar associations
for all anthropometric variables, when we conducted separate
analyses in participants who experienced ACS within the first 2
years of follow up and in participants who experienced an ACS
event after more than 2 years of follow up [3].
We adjusted for several potential confounders related to the
associations between obesity and ACS, but did not include
hypertension, diabetes mellitus and hypercholesterolemia in the
analyses of the presented results as they can be seen as
intermediate variables. Thus, their inclusion in multivariate
analyses would restrict the outcome to associations through other
pathways; however, analyses without these adjustments could lead
to confounding from other causes to these intermediate variables.
Crude analyses (Table S2), adjusted analyses (Table 3, 4 and 5)
and analyses with additional adjustment for hypertension, diabetes
mellitus and hypercholesterolemia (data not shown) provided
similar results, and thus we do not believe that residual
confounding explains our results.
General Discussion
The variant allele containing the deletion NFKB1-94ins/
delATTG promoter polymorphism leads to lower levels of the
p50 subunit, and this affects both the availability of the anti-
inflammatory p50/p50 NF-kB homodimer and the pro-inflam-
matory p50/p65 NF-kB heterodimer. However, the combined
effect of relatively low levels of both p50/p50 and p50/p65 will be
pro-inflammatory, as low p50 levels intuitively will affect the
concentration of p50/p50 more than the concentration of p50/
p65. Furthermore, the p50/p50 homodimer blocks binding sites
for the p65 subunit, and, thus, the level of the p50/p65
heterodimer will be relatively closer to normal, due to the
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controlled by the p50 homodimer. We have previously found
lower levels of CRP protein in serum from carriers of the del-allele
compared to ins-allele carriers, supporting the interpretation that
the del-allele causes depletion of p50 homodimer [14]. This is also
in line with the findings of increased levels of TNFalpha and IL-12
and reduced levels of IL-10 in NFKB1 knock-out mice [11].
However, the effect of the polymorphism may vary between
different tissues. Abdominal adipose tissue secretes a relatively
greater amount of pro-inflammatory cytokines than gluteofemoral
adipose tissue that secretes more anti-inflammatory cytokines [5].
Thus, in participants with high HC the net effect of the NFKB1-
94ins/delATTG promoter polymorphism may be a preferential
depletion of anti-inflammatory cytokines, and a reduction in the
protective effect of gluteofemoral fat deposits. Likewise, the
combined effect of abdominal obesity and homozygote variant
carrier status may be supra-additive due an excess secretion of pro-
inflammatory cytokines as well as an increased inflammatory
response to cytokines in atherosclerotic plaques. Even though our
results does show a tendency of positive interaction for abdominal
obesity and negative interaction for gluteofemoral obesity, and
thus supports the above mentioned biological hypothesis, potential
interaction between genetic variation in NFKB1 and obesity was
small and does not seem to be of clinical importance. However,
due to the importance of inflammation the development of
atherosclerosis further studies could be warranted to clarify the
biological implications of genetic variations in genes involved in
inflammation in relation to coronary heart disease.
In conclusion, we found no substantial interaction between the
NFKB1-94ins/delATTG promoter polymorphism and general,
abdominal, or gluteofemoral obesity.
Materials and Methods
Study Populations
The present study was based on three independent cohorts; the
Danish prospective study Diet, Cancer and Health (DCH), and
two US based cohorts; the Nurses’ Health Study (NHS) and the
Health Professionals Follow-up Study (HPFS). The Diet, Cancer
and Health study was approved by the National Committee on
Health Research Ethics (journal nr. (KF) 01-345/93) and the
Danish Data Protection Agency. Written informed consent was
obtained from all participants to search information from medical
registers.
All studies have previously been described in detail[17–19], and
thus only a brief description is presented here.
Diet, cancer and health. From November 1993 to May
1997, all men and women aged 50–64 years, born in Denmark,
living in the greater Copenhagen or Aarhus areas, and with no
previous cancer diagnosis registered in the Danish Cancer Registry
were invited to participate in Diet, Cancer and Health (DCH).
The study was approved by the National Committee on Health
Research Ethics (journal nr. (KF) 01-345/93) and the Danish Data
Protection Agency. Written informed consent was obtained from
all participants to search information from medical registers.
To preserve biological material the present study was conducted
as a case-cohort design based on a sex-stratified subcohort drawn
Table 1. Baseline characteristics of controls and cases of acute coronary syndrome.
Diet, Cancer and Health US cohorts
Men Women HPFS (men) NHS (women)
Controls Cases Controls Cases Controls Cases Controls Cases
Variable (n=922) (n=775) (n=797) (n=237) (n=873) (n=427) (n=922) (n=471)
Age 56.0 (51;63) 57.9 (52;64) 55.9 (51;63) 59.9 (52;64) 64.3 (52;76) 64.2 (51;75) 59.9 (50;67) 60.1 (51;68)
Educational level
Basic school 10.7% 15.1% 21.5% 31.7% 0% 0% 0% 0%
Higher education 1–2 years 13.5% 17.2% 31.2% 32.9% 0% 0% 69.7% 68.2%
Higher education 3–4 years 40.9% 40.4% 36.3% 29.1% 0% 0% 18.9% 19.1%
Higher education .4 years 34.9% 27.4% 11.0% 6.3% 100% 100% 9.1% 6.4%
Postmenopausal n/a n/a 58.1% 70.9% n/a n/a 87.5% 89.0%
Hormonal replacement therapy n/a n/a 31.4% 25.3% n/a n/a 37.4% 33.8%
Smoking status
Never smoker 26.5% 14.2% 42.0% 24.5% 41.2% 40.8% 36.2% 35.2%
Former smoker 34.9% 27.0% 21.6% 16.5% 50.3% 49.7% 38.1% 38.4%
Current 38.6% 58.8% 36.4% 59.1% 8.5% 9.6% 25.7% 26.3%
Alcohol (g/day) 19.9 (3.1;61.9) 16.6 (2.0;60.9) 8.8 (1.1;34.4) 6.0 (0.7;32.6) 13.1 (0.0;36.5) 10.3 (0.0;32) 6.1 (0.0;16.4) 4.3 (0.0;14.0)
Hypertension
1 13.9% 22.5% 16.1% 39.7% 29.0% 37.0% 28.3% 51.0%
Diabetes Mellitus
2 2.6% 5.0% 1.0% 5.5% 3.6% 9.6% 6.4% 15.1%
Hypercholesterolemia
3 9.4% 12.3% 5.9% 17.3% 40.6% 48.5% 40.9% 53.5%
Medians with 10th and 90th percentiles in brackets for continuous variables. Percentages for discrete variables. Diet, Cancer and Health, Health Professionals Follow-up
Study (HPFS), and Nurses’ Health Study (NHS).
1Self reported hypertension or reporting to use blood pressure lowering medication.
2Self reported or reporting to use antidiabetic medications.
3Self reported hypercholesterolemia or reporting to use cholesterol lowering medication.
doi:10.1371/journal.pone.0063004.t001
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excluded participants with an ACS diagnosis prior to baseline,
and participants for whom information on one or more variables
were missing.
All anthropometric data were collected by trained technicians.
Height was measured to the nearest 0.5 cm with the participants
standing without shoes. Weight was measured using a digital scale
with the participants wearing light clothing and recorded to the
nearest 0.1 kg. Waist circumference (WC) was recorded to the
nearest 0.5 cm and measured at the narrowest part between the
lower rib and the iliac crest.
Blood samples were collected from each participant at baseline,
and lymphocytes were isolated and frozen within 2 h. For
genotyping, DNA was isolated from frozen lymphocytes from
cases and participants in the subcohort and the NFKB1-94 ins/del
promoter polymorphism was determined as previously de-
scribed[14,20–22]. Controls were included in each run, and
repeated genotyping of a random 10% subset yielded 100%
identical genotypes [14].
Information on confounders was obtained at baseline through
questionnaires including socio-demographic factors, lifestyle,
medication and prevalent disease.
In Diet, Cancer and Health, ACS was defined as unstable
angina pectoris and myocardial infarction (ICD-8:410–410.99 and
ICD-10: I20.0, I21.0–I21.9). Potential cases were identified by
linkage to the Danish National Patient Registry [23] and the
Danish Causes of Death Registry using the Danish Civil
Registration System, in which every Danish citizen is identified
by a unique 10 digit number. All incident cases between baseline
and ultimo 2003 were validated by review of medical records in
accordance with the guidelines of the American Heart Association
and the European Society of Cardiology for use in epidemiology
[24]. Furthermore, participants with a sudden cardiac death
diagnosis (ICD 8:427.27 or ICD 10: I46.0–I46.9) were accepted as
cases, if the cardiac arrest at validation was believed to have been
caused by ACS.
A total of 80,996 men and 79,729 women were invited, and
27,148 men (34%) and 29,863 women (37%) consented to
participate. The sex stratified cohort sample consisted of 1869
participants. During a median follow up time of 6.8 years, 802
male and 250 female cases of incident ACS were diagnosed. After
exclusions of participants for whom information was missing on
the exposure variables or covariate data, there were 769 male and
224 female cases, and the subcohort comprised 1695 participants.
Participants in the subcohort may throughout the paper be
referred to as controls, even though the subcohort included 33
participants who had become cases.
The nurses’ health study and the health professionals
follow-up study. The Nurses’ Health Study (NHS) was
established in 1976 at the Channing Laboratory of the Brigham
and Women’s Hospital, Boston, US. The study included married,
female, registered nurses aged 30–55 years residing in one of 11
US states.
The Health Professionals Follow-up Study (HPFS) was estab-
lished at the Harvard School of Public Health in 1986 with
methods similar to that described for the NHS. It is a longitudinal
Table 2. Distribution of exposure variables according to case status.
Diet, Cancer and Health US cohorts
Men Women HPFS (men) NHS (women)
Controls Cases Controls Cases Controls Cases Controls Cases
Variable (n=922) (n=775) (n=797) (n=237) (n=873) (n=427) (n=922) (n=471)
Body Mass Index (kg/m
2) 26.4 (23;31) 27.0 (23;32) 24.6 (21;31) 26.2 (21;33) 25.6 (22;30) 26.1 (22;30) 25.1 (20;31) 26.6 (21;35)
BMI grouped according to WHO
Underweight 0.3% 0.1% 1.4% 1.3% 1.8% 1.6% 6.8% 6.2%
Normalweight 33% 27% 53% 38% 44% 36% 51% 40%
Overweight 51% 52% 33% 38% 44% 52% 29% 29%
Obese 16% 22% 13% 22% 11% 11% 13% 25%
Waist Circumference (cm) 95 (85;108) 97 (87;112) 80 (69;97) 86 (71;101) 98 (86;110) 99 (87;112) 79 (76;91) 82 (69;99)
WC grouped according to WHO
Female ,88 cm n/a n/a 74% 58% n/a n/a 84% 72%
Female $88 cm n/a n/a 26% 42% n/a n/a 16% 28%
Male ,102 cm 74% 65% n/a n/a 72% 66% n/a n/a
Male $102 cm 26% 35% n/a n/a 28% 34% n/a n/a
Hip Circumference (cm) 100 (93;108) 101 (93;110) 101 (92;113) 101 (91;114) 103 (94;112) 104 (94;114) 100 (89;112) 103 (91;119)
NFKB1-94ATTG polymorphism
Wildtype/Wildtype 40% (371) 35% (268) 38% (301) 38% (89) 39% (344) 36% (154) 39% (362) 39% (183)
Wildtype/Variant 45% (418) 48% (372) 47% (374) 47% (112) 45% (389) 51% (216) 45% (412) 45% (213)
Variant/Variant 14% (133) 17% (135) 15% (122) 15% (36) 16% (140) 13% (57) 16% (148) 16% (75)
Medians with 10th and 90th percentiles in brackets for continuous variables. Absolute numbers and/or percentages for discrete variables. Diet, Cancer and Health,
Health Professionals Follow-up Study (HPFS), and Nurses’ Health Study (NHS).
Note: Sample size in NHS and HPFS with data available on waist and hip circumfererence was lower (426/679 and 382/821, resspectively).
doi:10.1371/journal.pone.0063004.t002
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years at enrollment.
In both studies, the participants have received follow-up
questionnaires biennially to update information on lifestyle factors,
body weight, and newly diagnosed illnesses. Self-reported infor-
mation on height and weight was obtained at baseline, and self-
reported measures of WC and hip circumference (HC) were
obtained in 1986 in NHS and 1987 in HPFS, respectively.
In the NHS, blood samples were collected in 1989–1990 from
participants free of cardiovascular disease and cancer. Whole
blood samples were centrifuged and stored in cryotubes as plasma,
buffy coat, and red blood cells. DNA was extracted from the buffy
coat fraction of centrifuged blood with the QLAmp Blood Kit
(Qiagen, Chatsworth, CA, USA). The genotypes were determined
by Taqman SNP allelic discrimination by means of an ABI
7900HT (Applied Biosystems, Foster City, CA, USA)as previously
described [14,25]. Similarly, blood samples were collected from
participants from participants free of cardiovascular disease and
cancer in the HPFS in 1993–1995.
In both studies, anthropometric (except waist and hip measures
which were only obtained once in 1986/1987) and covariate data
were derived from questionnaires administered at blood draw
(1990 in the NHS and 1994 in the HPFS), with missing
information substituted from previous questionnaires [16,18].
Cases of ACS were in both NHS and HPFS defined as
myocardial infarction and fatal coronary heart disease. Potential
cases were participants who reported incident events on the follow-
up questionnaires and deceased participants. Deaths were
identified from state vital records and the National Death Index
or reported by the participant’s next of kin or the postal system.
Cases were validated primarily through review of medical records
by physicians blinded to the participant’s questionnaire reports
[26]. The diagnosis of myocardial infarction was confirmed on the
basis of the criteria of the World Health Organization, while fatal
coronary heart disease was confirmed by an examination of
hospital or autopsy records, by the listing of coronary heart disease
as the cause of death on the death certificate or if coronary heart
disease was the underlying and most plausible cause of death.
For the present study, we used nested case-control designs.
Blood was donated from 32,826 Nurses and 18,224 HPFS
participants. Between blood draw and June 2004, 512 female
incident cases of ACS were identified in NHS, and 454 male cases
were identified in HPFS. Using risk-set sampling, controls were
selected randomly and matched in a 2:1 ratio on age, smoking,
and month of blood return, among participants who were free of
cardiovascular disease at the time ACS was diagnosed in the case
patient [27].
After exclusions of participants for whom information was
missing on the NFKB1 genotype, body mass index and covariate
data, the NHS comprised 471 cases of incident ACS and 922
controls, and the HPFS comprised 427 cases and 875 controls.
However, information on WC and HC was not available for all
participants, and thus analyses regarding WC and HC only
included 426 cases and 679 controls in NHS and 382 cases and
821 controls in HPFS.
Table 3. RR* with 95% confidence interval in brackets for the combined effect of general obesity and the NFKB1-94ATTG
polymophism in relation to acute coronary syndrome.
MEN Diet, Cancer and Health
1 HPFS
2 Metaanalysis
NFKB1 NFKB1 NFKB1
Variable wt/wt wt/var var/var wt/wt wt/var var/var wt/wt wt/var var/var
Body mass index
,25 kg/m
2 1.00 (ref.) 1.14 (0.85; 1.53) 1.10 (0.73; 1.66) 1.00 (ref.) 1.04 (0.72; 1.50) 0.79 (0.46; 1.35) 1.00 (ref.) 1.10 (0.88; 1.38) 0.97
(0.70; 1.35)
25–29 kg/m
2 1.15 (0.86; 1.52) 1.40 (1.07; 1.84) 1.71 (1.24; 2.37) 1.21 (0.80; 1.85) 1.65 (1.11; 2.44) 1.07 (0.60;1.89) 1.17(0.92;1.48) 1.48 (1.18; 1.84) 1.52
(1.15; 2.02)
.29 kg/m
2 1.49 (1.08;2.05) 1.61 (1.20;2.18) 1.98 (1.35;2.91) 1.04 (0.59;1.82) 1.83 (1.11;3.04) 1.50 (0.68;3.27) 1.36 (1.03;1.80) 1.67 (1.29; 2.15) 1.88
(1.33; 2.65)
WOMEN Diet, Cancer and Health
1 NHS
2 Metaanalysis
NFKB1 NFKB1 NFKB1
Variable wt/wt wt/var var/var wt/wt wt/var var/var wt/wt wt/var var/var
Body mass index
,24 kg/m
2 1.00(ref.) 0.96(0.59;1.55) 0.69(0.32;1.47) 1.00(ref.) 0.97(0.66;1.42) 1.02(0.60;1.76) 1.00(ref.) 0.96 (0.71; 1.30) 0.90
(0.58; 1.39)
24–28 kg/m
2 1.15(0.67;1.97) 1.25(0.80;1.97) 0.91(0.44;1.86) 1.23(0.79;1.91) 1.22(0.81;1.84) 1.31(0.77;2.23) 1.20(0.85;1.69) 1.24 (0.91; 1.67) 1.15
(0.75; 1.77)
.28 kg/m
2 1.47 (0.88;2.45) 1.79 (1.10;2.89) 2.43 (1.35;4.37) 1.67 (1.08;2.58) 2.08 (1.34;3.22) 1.59 (0.84;3.03) 1.58 (1.14;2.21) 1.94 (1.41; 2.69) 2.00
(1.30; 3.09)
Diet, Cancer and Health, Health Professionals Follow-up Study (HPFS), and Nurses Health Study (NHS).
1Adjusted for age, smoking status, alcohol consumption, physical activity, and educational level. Women also adjusted for menopausal status.
2Adjusted for age, smoking status, alcohol consumption, and physical activity. Women also adjusted for menopausal status and hormone replacement therapy.
*RR estimated by Cox proportional hazards regression in DCH and logistic regression in NHS and HPFS.
doi:10.1371/journal.pone.0063004.t003
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In accordance with the case-cohort design and to allow for
delayed entry of the participants, the incidence rate ratios in DCH
were analyzed by weighted Cox’s proportional hazards regression
models with age as the underlying time variable [28,29]. The
observation time was censored by death of other causes than ACS,
emigration or study end at December 31
st 2003. Due to the nested
case-control design, incidence rate ratios were estimated by logistic
regression models in NHS and HPFS. Crude conditional and
unconditional analyses (adjusted for matching factors) showed very
similar results (data not shown). However, in the conditional
analyses a significant number of cases where missing a match due
to missing exposure/covariate information, and thus we chose to
provide results from unconditional analyses.
We used body mass index (BMI, calculated as the weight in
kilograms divided by the square of the height in meters) as a
measure of general obesity, and body fat distribution was
expressed as WC and HC mutually adjusted describing abdominal
and gluteofemoral obesity, respectively. The distribution of
anthropometric measures were described in tables according to
the WHO classification, but to achieve the best possible statistical
power, measures of obesity were included in the analyses as
categorical variables with 3 levels according to the distribution
among cases with the DCH cohort as reference (Men: BMI ,25,
25–29 and .29 kg/m
2;W C,94, 94–102 and .102 cm; HC
,98, 98–103.5 and .103.5 cm. Women: BMI ,24, 24–28 and
.28 kg/m
2;W C,80, 80–91 and .91 cm; HC ,98, 98–104
and .104 cm).
In DCH, we performed separate analyses in men and women
and adjusted for potential confounding from age, smoking status,
alcohol intake, physical activity (expressed as hours per week of
strenuous activities) educational level, and for women menopausal
status. In NHS and HPFS we adjusted for age, smoking status,
alcohol intake, and physical activity (expressed in terms of
metabolic equivalent (MET)-hours). In NHS we furthermore
adjusted for menopausal status and hormone replacement therapy.
Hypertension, diabetes mellitus, and hypercholesterolemia are
possible intermediate variables in analyses of anthropometry and
ACS, and therefore, they were not included in the main analyses.
Deviation from an additive model was explored as the relative
excess risk due to interaction (RERI) and calculated as suggested
by Rothman [30] and Hosmer and Lemeshow [31].
To combine the estimates from the three study populations, we
calculated the weighted average of the log rate ratios with weights
according to the study-specific variance. A similar model on
original scale was used to calculate the combined estimates of the
relative excess risk due to interaction.
The proportionality assumptions of the Cox proportional
hazards models were evaluated graphically by log-minus-log plots.
All analyses were performed using Stata version 11.2 (StataCorp
LP, College Station, TX) and SAS version 9 (SAS Institute Inc.,
Cary, NC).
Table 4. RR* with 95% confidence interval in brackets for the combined effect of abdominal obesity and the NFKB1-94ATTG
polymophism in relation to acute coronary syndrome.
MEN Diet, Cancer and Health
1 HPFS
2 Metaanalysis
NFKB1 NFKB1 NFKB1
Variable wt/wt wt/var var/var wt/wt wt/var var/var wt/wt wt/var var/var
Waist
circumference
,94 cm 1.00(ref.) 1.09(0.84;1.42) 1.04(0.71;1.52) 1.00(ref.) 1.05(0.68;1.63) 0.84(0.45;1.59) 1.00(ref.) 1.08 (0.86; 1.35) 0.98
(0.71; 1.36)
94–102 cm 1.04(0.78;1.38) 1.29(0.99;1.69) 1.56(1.14;2.15) 1.35(0.83;2.18) 1.17(0.74;1.85) 0.77(0.37;1.59) 1.11(0.87;1.42) 1.26 (1.00; 1.59) 1.39
(1.04; 1.86)
.102 cm 1.37 (0.98;1.91)1.55 (1.12;2.15) 2.00 (1.35;2.95) 0.98 (0.56;1.71) 1.54 (0.94;2.54) 1.10 (0.58;2.08) 1.25 (0.94;1.67) 1.55 (1.18; 2.03) 1.70
(1.22; 2.37)
WOMEN Diet, Cancer and Health
1 NHS
2 Metaanalysis
NFKB1 NFKB1 NFKB1
Variable wt/wt wt/var var/var wt/wt wt/var var/var wt/wt wt/var var/var
Waist
circumference
,80 cm 1.00(ref.) 0.92(0.57;1.48) 0.84(0.42;1.69) 1.00(ref.) 0.85(0.57;1.27) 0.97(0.57;1.67) 1.00(ref.) 0.88 (0.65; 1.20) 0.92
(0.60; 1.41)
80–91 cm 1.69(0.99;2.89) 1.68(1.03;2.76) 0.96(0.47;1.95) 0.87(0.51;1.48) 0.70(0.41;1.21) 0.72(0.35;1.46) 1.21(0.83;1.77) 1.13 (0.79; 1.63) 0.83
(0.50; 1.37)
.91 cm 2.07 (1.09;3.95)3.53 (1.96;6.35) 5.50 (2.53;12.0) 1.20 (0.64;2.26) 2.04 (1.05;3.99) 1.45 (0.59;3.57) 1.57 (1.00;2.46) 2.78 (1.79; 4.33) 3.11
(1.73; 5.60)
Diet, Cancer and Health, Health Professionals Follow-up Study (HPFS), and Nurses Health Study (NHS).
1Adjusted for age, smoking status, alcohol consumption, physical activity, educational level, and hip circumference. Women also adjusted for menopausal status.
2Adjusted for age, smoking status, alcohol consumption, physical activity, and hip circumference. Women also adjusted for menopausal status and hormone
replacement therapy.
*RR estimated by Cox proportional hazards regression in DCH and logistic regression in NHS and HPFS.
doi:10.1371/journal.pone.0063004.t004
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Table S1 RR* with 95% confidence interval in brackets for the
combined effect of obesity and the NFKB1-94ATTG polymoph-
ism in relation to acute coronary syndrome. Diet, Cancer and
Health, Health Professionals Follow-up Study (HPFS), and Nurses
Health Study (NHS).
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